Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.660
-0.120 (-3.17%)
Jan 17, 2025, 4:00 PM EST - Market closed
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 267 employees as of December 31, 2023. The number of employees increased by 48 or 21.92% compared to the previous year.
Employees
267
Change (1Y)
48
Growth (1Y)
21.92%
Revenue / Employee
$1,417,296
Profits / Employee
-$9,225
Market Cap
585.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
IRWD News
- 4 days ago - Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications - CNBC
- 7 weeks ago - Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 2 months ago - Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference - Business Wire
- 2 months ago - Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ironwood Pharmaceuticals Reports Third Quarter 2024 Results - Business Wire
- 3 months ago - Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024 - Business Wire
- 3 months ago - Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call - Business Wire
- 5 months ago - Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference - Business Wire